60
Participants
Start Date
July 7, 2025
Primary Completion Date
June 30, 2029
Study Completion Date
June 30, 2029
accelerated intermittent theta burst stimulation
Intermittent theta burst stimulation (iTBS), a FDA-approved form of noninvasive neuromodulation, can reduce neuropsychiatric symptoms and modulate inflammation in the thalamus as detected using dMRS, suggesting a potentially effective and efficient treatment approach with a pathophysiological component that is readily quantifiable.
RECRUITING
University of New Mexico Health Science Center, Albuquerque
The Mind Research Network
OTHER
United States Department of Defense
FED
University of New Mexico
OTHER